W-L Liu, Y-H Chiu, C-M Chao, C-C Hou, C-C Lai. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Abdominal Pain/diagnosisAbdominal Pain/drug therapyAbdominal Pain/microbiologyAbdominal Pain/physiopathologyAged, 80 and overAnti-Bacterial Agents/therapeutic useBile Ducts, Intrahepatic/drug effectsBile Ducts, Intrahepatic/microbiologyBile Ducts, Intrahepatic/pathologyCholedocholithiasis/diagnosisCholedocholithiasis/drug therapyCholedocholithiasis/microbiologyCholedocholithiasis/pathologyDiabetes Mellitus/immunologyDiagnosis, DifferentialFemaleGallstones/diagnosisGallstones/drug therapyGallstones/microbiologyGallstones/pathologyHumansImmunocompromised HostKidney Failure, Chronic/immunologyLiver Cirrhosis/immunologyPenicillanic Acid/analogs & derivativesPenicillanic Acid/therapeutic usePiperacillin/therapeutic useRisk FactorsTaiwanTazobactamTreatment OutcomeVibrio/drug effectsVibrio/isolation & purificationVibrio Infections/diagnosisVibrio Infections/drug therapyVibrio Infections/microbiologyVibrio Infections/pathologyVomiting/diagnosisVomiting/drug therapyVomiting/microbiologyVomiting/physiopathology
Substances: See more » Anti-Bacterial AgentsPenicillanic AcidTazobactamPiperacillin
Year: 2011 PMID: 21710120 DOI: 10.1007/s15010-011-0146-0
Source DB: PubMed Journal: Infection ISSN: 0300-8126 Impact factor: 3.553